相关实验视频

Updated: Jun 25, 2025

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

导航肝脏景观:对于原发性硬化胆管炎的即将出现的药物疗法

Hoang Nam Pham¹, Linh Pham², Keisaku Sato³

¹Department of Life Sciences, University of Science and Technology of Hanoi, Vietnam Academy of Science and Technology, Hanoi, Vietnam.

Expert opinion on pharmacotherapy

|May 30, 2024

概括

原发性硬化性脑膜炎 (PSC) 的治疗方法有限,在III期试验中,万科米辛显示出有前途. 目前正在进行的研究正在探索这种胆道疾病的新治疗点.

科学领域:

肝病学肝病学是一种肝病学.
胃肠病学胃肠病学
临床药理学临床药理学

背景情况:

初级硬化性胆道炎 (PSC) 是一种慢性胆道疾病,其病因不明,治疗选择有限.
目前用于PSC的治疗方法缺乏确定的疗效和安全性,需要进一步研究.
之前的临床试验针对了各种途径,包括胆酸信号和肠道微生物群,但取得了有限的成功.

研究的目的:

审查正在进行的和已完成的PSC临床试验 (第二阶段及以后).
讨论PSC治疗的潜在治疗目标和策略.
确定PSC药物开发的局限性和未来方向.

主要方法:

在PubMed和ClinicalTrials.gov的文献搜索中搜索PSC临床试验.
包括的研究是第二阶段或之后的研究.
关键词包括"原发性硬化性胆管炎"",临床试验"",抗生素"和特定药物的名称.

主要成果:

在PSC的第三阶段临床试验中,万科米辛治疗显示出有前途的结果.
在临床试验中评估的大多数其他候选药物显示无效或不一致的结果.
寻找有效和安全的PSC治疗方法的搜索仍然很活跃.

结论:

范科米辛代表了PSC的潜在治疗选择,需要进一步研究.
由于当前选择的有效性有限,开发针对PSC的新疗法至关重要.
对治疗目标和策略的持续研究对于推进PSC护理至关重要.

关键词:

原发性硬化性胆管炎的发生.胆固醇性肝损伤是什么意思临床研究临床研究.双管状反应反应是什么?肝炎是一种肝炎.肝脏纤维化肝脏纤维化

更多相关视频

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

相关概念视频

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...